Cite
HARVARD Citation
Nurbhai, S. et al. (n.d.). P668 Measured and modelled data suggest that oral administration of V565, a novel domain antibody to TNF-alpha, could be beneficial in the treatment of IBD. Journal of Crohn's and colitis. pp. S448-S449. [Online].